The Board of Directors at Synklino provides strategic guidance, oversight, and governance to ensure that the company remains focused on its mission to develop a CMV-specific immunotoxin. They supervise executive management, make high-level policy decisions, and ensure financial and regulatory compliance to drive the company toward sustainable growth and success.
Carit Jacques Anders...
CFO
Christine Flarup Møl...
Board Member
Jette Wagtberg Sen
COO
John Haurum
Chairman
Josefin-Beate Holz
CMO
Mads Lacoppidan
Board Member
Mads Laustsen
Board Member
Magnus Persson
Board Member
Mette M Rosenkilde
Member of the Board of Directo...
Morten Schrøder
Board Member
Thomas Feldthus
Board Member
Thomas Kledal
CEO & Co-Founder
View all